Affordable Access

Publisher Website

Polymorphism rs4919510:C>G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes

Public Library of Science
Publication Date
DOI: 10.1371/journal.pone.0035252
  • Research Article
  • Biology
  • Biochemistry
  • Nucleic Acids
  • Rna
  • Rna Interference
  • Computational Biology
  • Population Genetics
  • Genetic Polymorphism
  • Medicine
  • Epidemiology
  • Molecular Epidemiology
  • Obstetrics And Gynecology
  • Breast Cancer
  • Oncology
  • Cancer Risk Factors
  • Genetic Causes Of Cancer
  • Biology
  • Computer Science
  • Medicine


Background A few polymorphisms are located in the mature microRNA sequences. Such polymorphisms could directly affect the binding of microRNA to hundreds of target mRNAs. It remains unknown whether rs4919510:C>G located in the mature miR-608 alters breast cancer susceptibility. Methods The association of rs4919510:C>G with risk and pathologic features of breast cancer were investigated in two independent case-control studies, the first set including 1,138 sporadic breast cancer patients (including 927 invasive ductal carcinoma patients, 777 of them with known subtypes: 496 luminal-like, 133 HER2-positive, and 148 triple-negative) and 1,434 community-based controls, and the second set including 294 familial/early-onset breast cancer patients and 500 hospital-based cancer-free controls. Odds ratios (ORs) were estimated by logistic regression. Predicted targets of miR-608 and complementary sequences containing rs4919510:C>G were surveyed to reveal potential pathological mechanism. Results In the first set, although rs4919510:C>G was unrelated to breast cancer in general patients, variant genotypes (CG/GG) were specifically associated with increased risk of HER2-positive subtype (Adjusted OR = 1.97, 95% CI, 1.34−2.90 in the recessive model). Variant G-allele was the risk allele with OR of 1.62 (95% CI, 1.23−2.15). Patients carrying GG-genotype also had larger HER2-positive tumors (P for Kruskal-Wallis test = 0.006). The relationship between rs4919510:C>G and risk of HER2-positive subgroup was validated in the second set (Bonferroni corrected P = 0.06). The adjusted combined OR (total 164 HER2-positive cases) in the recessive model was 1.97 (95% CI, 1.43−2.72) for GG genotype (corrected P = 1.1×10−4). Bioinformatic analysis indicated that, HSF1, which is required for HER2-induced tumorigenesis, might be a target of miR-608. The minimum free-energy of ancestral-miR-608 (C-allele) binding to HSF1 is −35.9 kcal/mol, while that of variant-form (G-allele) is −31.5 kcal/mol, indicating a lower affinity of variant-miR-608 to HSF1 mRNA. Conclusion rs4919510:C>G in mature miR-608 may influence HER2-positive breast cancer risk and tumor proliferation.

There are no comments yet on this publication. Be the first to share your thoughts.